image
Syros Pharmaceuticals, Inc. SYRS
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 0.2593
-5.74 %
$ 6.96 M
Market Cap
-0.08
P/E
INCOME STATEMENT
9.94 M REVENUE
-33.23%
Growth Rates
1Year -33.23%
3Years -13.01%
5Years 37.12%
7Years 63.58%
10Years 0.00%
-129 M OPERATING INCOME
5.07%
Growth Rates
1Year 5.07%
3Years -16.16%
5Years -14.94%
7Years -15.18%
10Years -31.05%
-165 M NET INCOME
-73.87%
Growth Rates
1Year -73.87%
3Years -25.11%
5Years -21.45%
7Years -19.34%
10Years -34.23%
EFFICIENCY
Earnings Waterfall Syros Pharmaceuticals, Inc.
image
Revenue 9.94 M
Cost Of Revenue 108 M
Gross Profit -98.2 M
Operating Expenses 30.8 M
Operating Income -129 M
Other Expenses 35.6 M
Net Income -165 M

Income Statement

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014 Dec-2013
REVENUE
Revenue 9.9 14.9 23.5 15.1 2.0 2.0 1.1 0.3 0.3 0 0
GROSS PROFIT
Cost Of Revenue 108.2 3.0 0 0 0 0 1.5 0 0.6 0 0
Gross Profit (98.2) 11.9 23.5 15.1 2.0 2.0 (0.4) 0.3 (0.3) 0 0
OPERATING INCOME
Operating Expenses 30.8 141.2 122.9 97.4 79.7 66.3 55.8 48.3 30.1 13.4 8.7
Selling, General and Administrative Expenses 28.3 29.3 23.0 21.3 21.5 16.2 13.9 10.5 5.7 2.5 2.4
Research and Development Expenses 108.2 111.9 99.9 76.1 58.2 50.2 41.9 37.8 24.4 10.9 6.3
Operating Income (129.0) (135.9) (99.4) (82.3) (77.7) (64.3) (54.7) (48.0) (29.8) (13.4) (8.6)
PRE-TAX INCOME
Interest Income Expense 5.1 4.1 3.9 1.8 0 0 0 0 0 0 0
Total Other Income (35.6) 41.2 12.9 (1.7) 2.3 2.0 0.7 0.2 2 K 4 K 32 K
Pre-Tax Income (164.6) (94.7) (86.6) (84.0) (75.4) (62.3) (54.0) (47.7) (29.8) (13.4) (8.7)
NET INCOME
Tax Provision 0 (45.4) 3.9 1.8 2.6 2.0 (1.5) 0 0 0 0.6
Net Income (164.6) (49.3) (90.5) (85.8) (75.4) (62.3) (54.0) (47.7) (29.8) (13.4) (9.3)
EPS 5.81 3.9 14.5 18.6 18.8 19.1 21.3 37.6 120 54.2 84.5